CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- SC 13G Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 4 Grant or award Chief Financial Officer acquired 31,260 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Option exercise Director acquired 15,000 shares (option exercise)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Open-market sale Principal Accounting Officer sold 7,727 shares at $3.43 ($26,504)
- 4 Open-market sale SVP and General Counsel sold 13,381 shares at an average $3.43 ($45,963)
- 4 Open-market sale Chief People Officer sold 14,700 shares at an average $3.43 ($50,439)
Page 14 of 42 · 836 filings